I value being part of the largest and fastest growing user community of its kind in the world
Instem Client
Gencell to Implement Provantis Pathology
July 2004
Instem is pleased to announce that Gencell of Paris, France has become the latest Provantis Pathology customer. Gencell, a fully owned biopharmaceutical subsidiary of Aventis Pharma S.A., is focused on the treatment of cancer and cardiovascular diseases.
The Provantis Pathology module will be used by Gencell in support of their work in discovering and developing biopharmaceutical products.
Dr. Emmanuel Pham, Head of Biostatistics and Bioinformatics, Gencell stated, "Provantis Pathology was a clear choice based upon a winning package of strong functionality, modern technology, regulatory compliance and competitive price."
About Instem
Instem is a world-leading information solutions provider for the Life Sciences - accelerating drug and chemical development by increasing client productivity and enhancing the processes that lead to safer, more effective products.
Established in 1969, Instem has offices in the United States and Europe with its solutions supported in thirteen countries. Instem serves large multi-national corporations and smaller organizations in overcoming the challenges of managing information and provides solutions that help them further their missions while creating a competitive advantage. For more information on Instem and its solutions, please visit www.instem.com or contact them by email at info@instem.com.
Press Contact:
Gary E. Mitchell, VP Global Marketing, Instem US HQ
Tel: (610) 941-0990
Email: gary.mitchell@instem.com
All trademarks used are properties of their respective owners.
Links
Accessibility
Contact Us
© 2001 - 2010 Instem - All rights reserved